deltatrials

Acute respiratory distress syndrome Trials in New York, United States

Conditions / Acute respiratory distress syndrome / New York, United States

Acute respiratory distress syndrome is a medical condition with active clinical research programs worldwide.

23 total trials for this combination

Showing top 10 of 23 trials

Trials

NCT ID Title Status Phase
NCT05947955 Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS) RECRUITING PHASE2
NCT04388813 Predictors of Severe COVID-19 Outcomes COMPLETED
NCT00879606 Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome COMPLETED PHASE2
NCT04384445 Zofin (Organicell Flow) for Patients With COVID-19 COMPLETED PHASE1/PHASE2
NCT00521625 Epidemiologic Multicenter Study on Mechanical Ventilation Management in Children With Acute Lung Injury COMPLETED
NCT04291508 Acetaminophen and Ascorbate in Sepsis: Targeted Therapy to Enhance Recovery COMPLETED PHASE2
NCT03096314 Vitamin D to Improve Outcomes by Leveraging Early Treatment COMPLETED PHASE3
NCT05388708 ARDS in Children and ECMO Initiation Strategies Impact on Neurodevelopment (ASCEND) RECRUITING
NCT05228717 Point-of-care Lung Ultrasound (POCUS)-Integrated Study of Admitted Patients With COVID-19 UNKNOWN
NCT00970606 STIP: Statin Trial for Influenza Patients TERMINATED NA

Related Pages